Stocks › TWST

Twist Bioscience Corp

TWST·Nasdaq·United States United States·USD
$166.97
-38.03 (-18.55%)
Close · Oct 6, 2026 · Close Prices from Tiingo.com
TWST
Twist Bioscience Corp · Nasdaq
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
TWSTS&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair

Congressional Trades

Recent trades of TWST by members of U.S. Congress · 2 on record
All congressional trades →
PoliticianStockTypeFiledTraded
Dwight EvansDwight EvansHouse · D · PA TWSTTwist Bioscience Corp · Stock Sale
$1,001 - $15,000
Apr 25, 2022 Mar 30, 2022 Filing ↗
Dwight EvansDwight EvansHouse · D · PA TWSTTwist Bioscience Corp · Stock Purchase
$1,001 - $15,000
Apr 23, 2020 Mar 2, 2020 Filing ↗

Whale Activity

Position changes in TWST reported for 2026-06-30 by 18 tracked institutional filers
Increased: 5New: 1Decreased: 2Closed: 1No prior filing: 9
  • Increased5
  • New1
  • Held0
  • Decreased2
  • Closed1
  • No prior filing9

KeyVex tracks a curated set of large 13F filers plus the largest positions in recent filings, so this is a sample of institutional activity, not the whole market.

Insider Trading

Net shares bought (+) or sold (−) on the open market by TWST insiders, by quarter · Form 4
-1.0M-500.0K0500.0K1.0M2025 Q1: -41.7K2025 Q12025 Q2: -54.0K2025 Q22025 Q3: -30.3K2025 Q32025 Q4: -184.9K2025 Q42026 Q1: -212.6K2026 Q12026 Q2: -222.3K2026 Q22026 Q3: -702.3K2026 Q32026 Q4: -101.2K2026 Q4

Recent Insider Transactions

1,819 transactions on record · newest first
All insider activity →
InsiderTypeSharesPriceValueDate
Leproust Emily M.Chief Executive Officer · Director Sale −45.7K $188.88 $8.6M Oct 2, 2026 Form 4 ↗
WERNER ROBERT F.Chief Accounting Officer Sale −1,482 $188.88 $280K Oct 2, 2026 Form 4 ↗
Laponis AdamChief Financial Officer Sale −8,057 $188.88 $1.5M Oct 2, 2026 Form 4 ↗
Green PaulaSVP of Human Resources Sale −10.1K $188.88 $1.9M Oct 2, 2026 Form 4 ↗
Finn Patrick JohnPresident and COO Sale −25.7K $188.88 $4.9M Oct 2, 2026 Form 4 ↗
Cho DennisSee Remarks Sale −9,514 $188.88 $1.8M Oct 2, 2026 Form 4 ↗
Leproust Emily M.Chief Executive Officer · Director Sale −655 $200.00 $131K Oct 1, 2026 Form 4 ↗
Leproust Emily M.Chief Executive Officer · Director Sale −945 $176.39 $167K Sep 24, 2026 Form 4 ↗
Leproust Emily M.Chief Executive Officer · Director Sale −83 $184.60 $15K Sep 24, 2026 Form 4 ↗
Leproust Emily M.Chief Executive Officer · Director Sale −515 $180.39 $93K Sep 24, 2026 Form 4 ↗
Leproust Emily M.Chief Executive Officer · Director Sale −501 $183.76 $92K Sep 24, 2026 Form 4 ↗
Leproust Emily M.Chief Executive Officer · Director Sale −330 $178.67 $59K Sep 24, 2026 Form 4 ↗
Leproust Emily M.Chief Executive Officer · Director Sale −2,485 $175.23 $435K Sep 24, 2026 Form 4 ↗
Leproust Emily M.Chief Executive Officer · Director Sale −21 $181.45 $4K Sep 24, 2026 Form 4 ↗
Leproust Emily M.Chief Executive Officer · Director Sale −164 $177.17 $29K Sep 24, 2026 Form 4 ↗
Leproust Emily M.Chief Executive Officer · Director Sale −16 $182.50 $3K Sep 24, 2026 Form 4 ↗
Leproust Emily M.Chief Executive Officer · Director Sale −143 $179.93 $26K Sep 24, 2026 Form 4 ↗
Cho DennisSee Remarks Sale −348 $165.49 $58K Sep 21, 2026 Form 4 ↗
Green PaulaSVP of Human Resources Sale −294 $165.49 $49K Sep 21, 2026 Form 4 ↗
Leproust Emily M.Chief Executive Officer · Director Sale −1,687 $165.49 $279K Sep 21, 2026 Form 4 ↗

Fund Holders

Mutual funds and ETFs holding TWST · SEC Form N-PORT
FundSharesValue% of fundAs of
VANGUARD TOTAL STOCK MARKET INDEX FUND
VANGUARD INDEX FUNDS
1.9M$192.8M0.01%Jun 30, 2026
ARK Innovation ETF
ARK ETF Trust
2.0M$184.1M3.31%Jul 31, 2026
iShares Russell 2000 ETF
iShares Trust
1.6M$164.0M0.20%Jun 30, 2026
State Street(R) SPDR(R) S&P(R) Biotech ETF
SPDR SERIES TRUST
1.5M$151.1M1.41%Jun 30, 2026
VANGUARD SMALL-CAP INDEX FUND
VANGUARD INDEX FUNDS
1.4M$139.6M0.07%Jun 30, 2026
ARK Genomic Revolution ETF
ARK ETF Trust
1.3M$120.4M7.73%Jul 31, 2026
T. Rowe Price New Horizons Fund, Inc.959.3K$98.7M0.67%Jun 30, 2026
Artisan Mid Cap Fund
Artisan Partners Funds Inc.
893.2K$91.9M2.88%Jun 30, 2026
Bridge Builder Small/Mid Cap Growth Fund
Bridge Builder Trust
866.9K$89.2M0.80%Jun 30, 2026
VANGUARD SMALL-CAP GROWTH INDEX FUND
VANGUARD INDEX FUNDS
780.8K$80.3M0.17%Jun 30, 2026

Mutual funds and ETFs whose N-PORT filings list TWST's shares (CUSIP 90184D100), each fund at its latest report since Mar 7, 2026, largest positions first. Bonds, options and short positions are left out.

Activist & Passive Stakes

Schedule 13D / 13G beneficial-ownership filings
  • Catherine D. WoodSCHEDULE 13G/A · passive (13G) · 3.4M shares5.1%
    Sep 8, 2026 · ↗
  • ARK Investment Management LLCSCHEDULE 13G/A · passive (13G) · 3.4M shares5.1%
    Sep 8, 2026 · ↗
  • Abigail P. JohnsonSCHEDULE 13G/A · passive (13G) · 8.8M shares13.2%
    Sep 8, 2026 · ↗
  • FMR LLCSCHEDULE 13G/A · passive (13G) · 8.8M shares13.2%
    Sep 8, 2026 · ↗
  • EdgePoint Investment Group Inc.SCHEDULE 13G/A · passive (13G) · 2.5M shares4.2%
    Aug 14, 2026 · ↗
  • Catherine D. WoodSCHEDULE 13G/A · passive (13G) · 4.5M shares7.3%
    Aug 14, 2026 · ↗
  • ARK Investment Management LLCSCHEDULE 13G/A · passive (13G) · 4.5M shares7.3%
    Aug 14, 2026 · ↗
  • T. Rowe Price Associates, Inc.SCHEDULE 13G · passive (13G) · 3.6M shares5.8%
    Aug 14, 2026 · ↗
  • Artisan Partners Limited PartnershipSCHEDULE 13G/A · passive (13G) · 4.8M shares7.7%
    Aug 13, 2026 · ↗
  • Artisan Investments GP LLCSCHEDULE 13G/A · passive (13G) · 4.8M shares7.7%
    Aug 13, 2026 · ↗

Corporate Lobbying

Estimated quarterly lobbying spending reported under the LDA, filings naming twist bioscience as client
$0$125K$250K$375K$500K2023 Q1: $29K2023 Q2: $44K2023 Q3: $44K2023 Q4: $44K20232024 Q1: $46K2024 Q2: $46K2024 Q3: $47K2024 Q4: $47K20242025 Q1: $75K2025 Q2: $75K2025 Q3: $75K2025 Q4: $75K20252026 Q1: $83K2026 Q2: $83K2026
  • IPOLICY SOLUTIONSTWIST BIOSCIENCE CORPORATION · 2026 Q2 · SCI, TRD$83K
    Filing ↗
  • IPOLICY SOLUTIONSTWIST BIOSCIENCE CORPORATION · 2026 Q1 · SCI, TRD$83K
    Filing ↗
  • IPOLICY SOLUTIONSTWIST BIOSCIENCE CORPORATION · 2025 Q4 · SCI, DEF, TRD$75K
    Filing ↗
  • IPOLICY SOLUTIONSTWIST BIOSCIENCE CORPORATION · 2025 Q3 · INT, CPT, SCI$75K
    Filing ↗
  • IPOLICY SOLUTIONSTWIST BIOSCIENCE CORPORATION · 2025 Q2 · INT, CPT, TAR, SCI$75K
    Filing ↗

Government Contracts

Federal awards to twist bioscience · USAspending
$228KAwarded · 4 contracts on record
  • Department of Veterans AffairsSHAHRARA HUMANIZED MONOCLONAL ANTIBODY FOR SYNDECAN TWIST BIOSCIENCE$105K
    Sep 18, 2024 · ↗
  • Department of Health and Human ServicesTHE PURPOSE OF THIS PURCHASE ORDER IS TO PROVIDE THE NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES / DIVISION OF TRANSLATIONAL TOXICOL$27K
    Jul 30, 2026 · ↗
  • Department of Health and Human ServicesTWIST BIOSCIENCE$0
    Dec 18, 2020 · ↗
  • Department of JusticeTWIST BIOSCIENCE EQUIPMENT$97K
    Jun 29, 2026 · ↗

U.S. Patents

Recent USPTO applications naming Twist Bioscience Corp

No USPTO patent applications found for Twist Bioscience Corp.

Annual Financials

From TWST's 10-K filings · XBRL

No annual XBRL figures on record for TWST. KeyVex's fundamentals cover about 130 large companies so far.

Stock Splits

Every split and reverse split in the price history

No stock splits in TWST's price history.

Material Events (8-K)

Corporate events filed with the SEC
  • 8-K · Items 7.01Reg FD disclosureAug 19, 2026
    EDGAR ↗
  • 8-K · Items 8.01, 9.01Other eventsAug 19, 2026
    EDGAR ↗
  • 8-K · Items 1.01, 7.01, 9.01Material agreement · Reg FD disclosureAug 5, 2026
    EDGAR ↗
  • 8-K · Items 2.02, 9.01Results of operationsAug 3, 2026
    EDGAR ↗
  • 8-K · Items 2.02, 9.01Results of operationsMay 4, 2026
    EDGAR ↗

About Twist Bioscience Corp

From SEC EDGAR company records
Industry (SIC 2836)Biological Products, (No Diagnostic Substances)
SectorHealthcare
HeadquartersSOUTH SAN FRANCISCO, CA
IncorporatedDE